VSEE — Vsee Health Cashflow Statement
0.000.00%
- $16.18m
- $26.29m
- $10.42m
- 27
- 42
- 18
- 18
Annual cashflow statement for Vsee Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.259 | 0.278 | -0.926 | -3.41 | -57.7 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | — | -0.133 | 0.096 | -0.072 | 55.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.448 | -0.696 | 0.699 | 0.996 | -3.21 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 0.789 | -0.46 | -0.826 | -0.633 | -5.79 |
| Capital Expenditures | — | — | 0 | -0.004 | -0.055 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.029 |
| Sale of Business | |||||
| Cash from Investing Activities | — | — | 0 | -0.004 | -0.026 |
| Financing Cash Flow Items | -0.217 | — | 0 | 0.135 | 1.09 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.084 | 0.031 | 0.71 | 0.525 | 6.02 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.705 | -0.429 | -0.116 | -0.112 | 0.207 |